Exercise of options
Faron Pharmaceuticals Ltd. (“Faron”) Exercise of options Issue of equity Company announcement, June 1, 2022 at 07:00 am BST / 9:00 am EEST TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, announces that it has received notifications from option holders to exercise 2015D options over 25,000 shares in the Company at an exercise price of EUR 1.09 (approx.